How To Prevent Keloids And Pih In Darker Skin During Deep Tissue Rejuvenation? Safe Protocols & Tips

Darker skin phenotypes require a lower-trauma, lower-heat treatment strategy. Before performing deep tissue rejuvenation, microneedling RF, laser, injectable, or other invasive procedures, clinics should assess pigmentary and scarring risk, select conservative parameters, protect the epidermis, and establish a documented response plan. Deep treatment does not eliminate risk: needle entry, heat, inflammation, infection, and excessive tension can all trigger PIH or abnormal scarring.

The safest approach is controlled treatment of the intended deep tissue plane with minimal epidermal injury, conservative energy delivery, strict cooling and photoprotection, and early management of inflammation or abnormal scarring.

Assess Risk Before Treating

Document phenotype and baseline pigmentation

Record the patient’s Fitzpatrick phototype, baseline pigmentation, history of PIH, melasma, uneven tone, acne inflammation, and prior reactions to lasers, injections, surgery, or needling.

Fitzpatrick classification is useful for laser planning but does not fully predict scarring or pigmentary behavior. Clinical history is often more informative than skin tone alone.

Screen specifically for keloids

Ask about personal and family history of keloids and hypertrophic scars, including scars from piercings, vaccinations, acne, surgery, burns, and minor injuries.

Pay particular attention to high-risk areas such as the chest, shoulders, jawline, and upper back. Elective invasive treatment should be reconsidered when the patient has active keloids, poorly controlled inflammatory skin disease, or a strong history of abnormal scarring.

Examine the treatment area

Do not treat through active acne, folliculitis, dermatitis, infection, open wounds, recent sunburn, or significant irritation.

Document pre-existing scars, pigment irregularity, tattoos, and lesions. This establishes a baseline and helps distinguish treatment-related changes from pre-existing findings.

Obtain risk-specific consent

Consent should address the possibility of persistent PIH, hypopigmentation, burns, delayed healing, hypertrophic scarring, and keloid formation.

Patients should also understand that conservative treatment may require multiple sessions and may produce less immediate tightening than aggressive treatment.

Plan Treatment Around Tissue Depth

Target the intended deep plane

For rejuvenation procedures, treatment should be directed toward the clinically intended deep dermis, subcutaneous tissue, or deeper structural plane, rather than creating unnecessary superficial trauma.

For lifting or repositioning procedures, avoid achieving correction primarily by aggressively pulling the skin. Where clinically appropriate, structural support should be addressed in deeper tissue planes, such as the SMAS, rather than placing excessive tension on the epidermis and superficial dermis.

Minimize epidermal disruption

Limit unnecessary needle punctures, passes, overlapping, and mechanical abrasion. Deeper placement can reduce superficial injury, but it does not make a procedure risk-free; entry points and thermal spread can still provoke PIH.

Use the smallest number of treatment passes and punctures consistent with the intended result.

Select devices that preserve the epidermis

Microneedling RF and other systems that deliver energy into the dermis while limiting epidermal heating may be preferable to highly aggressive superficial resurfacing in appropriately selected patients.

A device is not inherently safe because it is marketed for darker skin. Safety depends on wavelength, pulse duration, energy density, treatment depth, cooling, operator technique, and patient selection.

Control Energy and Heat

Use conservative initial parameters

Begin with lower fluence, lower density, fewer passes, and appropriate pulse durations for the patient’s phenotype and treatment area.

Multiple controlled passes at lower energy may be safer than a single high-fluence pass, provided the device protocol supports that approach and cumulative heating is carefully monitored.

Perform a test spot when appropriate

For laser, IPL, and other energy-based procedures, use a test spot when the device, indication, and clinical circumstances make it appropriate.

Observe for delayed erythema, blistering, crusting, pigmentary change, or prolonged inflammation before treating a larger area. A test spot reduces uncertainty but cannot guarantee the absence of complications.

Maintain full handpiece contact

The handpiece should remain flush and stable against the skin during pulse delivery when required by the device protocol.

Incomplete contact or uneven pressure can produce inconsistent energy delivery, localized overheating, and burns. Operators should follow the manufacturer’s instructions for contact cooling, coupling, and movement.

Use active cooling

Use integrated contact cooling, forced cold air, or another validated cooling method when compatible with the device.

Cooling should continue immediately after treatment when indicated. It reduces thermal injury and discomfort but does not compensate for excessive fluence, poor contact, or excessive passes.

Protect the dermo-epidermal junction

The clinical objective is to stimulate the deeper dermal matrix while limiting unnecessary injury to the epidermis and dermo-epidermal junction.

Ablative resurfacing, high-density fractional treatments, and aggressive IPL require particular caution in Fitzpatrick IV–VI skin because thermal and inflammatory injury can produce prolonged PIH or hypopigmentation.

Prepare the Skin Before Treatment

Defer treatment after sun exposure

Assess recent tanning, sunburn, outdoor exposure, and use of tanning devices. Defer treatment when the skin is recently tanned, inflamed, or sun-damaged.

Patients should begin broad-spectrum sunscreen use before treatment and maintain strict UV avoidance afterward. A sunscreen with SPF 30 or higher is a practical minimum, with reapplication and protective clothing when exposure is unavoidable.

Consider preconditioning for pigment-prone patients

For patients with previous PIH, melasma, or substantial baseline dyschromia, consider a supervised pre-treatment pigment-control regimen for approximately 2–6 weeks, depending on the procedure and the patient’s tolerance.

The exact topical agent should be selected by a qualified clinician. Irritating or overly aggressive “priming” can itself cause inflammation and worsen PIH, so treatment should be stopped if significant irritation develops.

Treat active inflammation first

Do not proceed simply because the planned procedure is deep. Active acne, eczema, folliculitis, or other inflammation increases the likelihood of additional pigmentary change and delayed healing.

Stabilize the skin barrier and underlying condition before performing elective invasive treatment.

Use Aseptic and Scar-Prevention Protocols

Reduce infection and prolonged inflammation

Use appropriate skin antisepsis, sterile or single-use components, clean technique, and device-specific infection-control procedures.

Infection, persistent crusting, and delayed wound healing can substantially increase the risk of PIH and abnormal scarring. Patients should receive clear instructions about hand hygiene, cleansing, dressing, and signs of infection.

Avoid excessive mechanical tension

Aggressive skin traction, over-tightening, and high-tension closure can contribute to hypertrophic scarring and keloid formation.

For procedures involving incisions, sutures, or tissue repositioning, use sound surgical technique, minimize dead space and tension where possible, and consider early scar surveillance in high-risk patients.

Establish an early scar-response plan

Patients with a strong keloid history should be managed cautiously, and elective treatment may require consultation with a dermatologist or plastic surgeon experienced in scar disorders.

If a scar becomes raised, itchy, painful, expanding, or extends beyond the original injury, assess it early. Silicone-based scar therapy, pressure strategies, intralesional corticosteroids, or other interventions may be appropriate, but should be selected and administered by a qualified clinician.

Manage the Immediate Recovery Period

Cool and calm the skin

Use appropriate post-treatment cooling and a bland, non-comedogenic moisturizer or emollient to support the barrier.

Avoid unnecessary friction, picking, exfoliating acids, retinoids, fragranced products, and heat exposure until the skin has recovered according to the procedure-specific protocol.

Enforce photoprotection

Immediate and continuing UV protection is central to PIH prevention. Patients should use broad-spectrum sunscreen, reapply it as directed, and minimize direct sun exposure during the inflammatory and pigment-forming phases of healing.

Visible-light protection may also be relevant for some pigment-prone patients, particularly those with melasma, and should be discussed according to the clinician’s assessment.

Control inflammation without irritating the skin

Topical anti-inflammatory or pigment-modulating therapy may be considered when clinically appropriate.

Do not automatically apply multiple depigmenting products immediately after treatment. Some agents can irritate compromised skin and create more inflammation; timing should be based on re-epithelialization, the procedure performed, and the patient’s response.

Monitor instead of assuming normal healing

Schedule follow-up appropriate to the procedure and risk profile. Persistent erythema, increasing pain, drainage, blistering, delayed epithelialization, rapidly darkening pigmentation, or a raised expanding scar requires prompt clinical review.

Understanding the Trade-offs

Deeper treatment is not automatically safer

Deep placement may reduce superficial epidermal trauma, but it introduces other risks, including vascular injury, nodules, burns, contour irregularity, and injury to deeper structures.

Depth must therefore be guided by anatomy, indication, device design, and operator training—not used as a universal substitute for conservative treatment.

Lower settings may require more sessions

Reducing energy, density, or passes can lower the risk of PIH and scarring, but it may also reduce the immediate clinical effect.

Patients should receive realistic expectations rather than being exposed to excessive energy in pursuit of a single-session result.

Fractional does not mean risk-free

Fractional lasers and IPL treat only portions of the skin, but each treated zone can still develop thermal injury and PIH.

Lower density, fewer passes, conservative fluence, adequate cooling, and longer intervals between sessions are important when treating darker phenotypes.

Keloids cannot always be prevented

Careful technique reduces avoidable triggers but does not eliminate individual susceptibility.

A patient with previous keloids may develop one after relatively minor trauma, making candidacy, treatment location, consent, and follow-up as important as the device settings.

Making the Right Choice for Your Goal

The protocol should be individualized to the procedure, anatomical site, skin phenotype, medical history, and prior treatment response.

If your primary focus is preventing PIH: Use conservative energy and density, minimize epidermal trauma, perform test spots when appropriate, maintain active cooling, defer treatment after sun exposure, and enforce strict post-procedure photoprotection.
If your primary focus is preventing keloids: Screen for personal and family history, avoid elective treatment through active scars or inflammation, minimize mechanical tension and tissue trauma, and arrange early review of any raised or expanding scar.
If your primary focus is deep tissue rejuvenation: Treat the intended deep dermal, subcutaneous, or structural plane while avoiding aggressive superficial pulling, excessive passes, and unnecessary epidermal heating.
If your primary focus is operational safety: Use trained clinicians, device-specific protocols, appropriate eye protection, sterile technique, documented parameters, test spots when indicated, and a clear escalation pathway for burns, infection, PIH, or abnormal scarring.

The safest aesthetic practice for darker skin phenotypes is deliberate, anatomically informed, conservative, and supported by structured follow-up rather than aggressive treatment intensity.

Summary Table:

Key Consideration	Recommended Protocol
Risk Assessment	Document Fitzpatrick type & history of PIH/keloids
Treatment Planning	Use conservative energy, test spots, and active cooling
Epidermal Protection	Minimize needle passes and thermal injury; use fractional/needling RF
Pre-Treatment	Apply pigment-control regimen and strict photoprotection
Post-Treatment	Cool skin, enforce sunscreen, monitor for early signs of scarring
Scar Management	Early intervention with silicone, corticosteroids if needed

Ensure the safety of your darker-skinned clients with BELIS's advanced aesthetic devices designed for controlled, conservative treatment. Our portfolio includes Microneedle RF, fractional lasers, and more, perfect for clinics prioritizing safety. Contact us today to discuss how we can support your practice with reliable equipment and expert guidance. Contact us now to learn more!

How to Prevent Keloids and PIH in Darker Skin During Deep Tissue Rejuvenation? Safe Protocols & Tips